FDA.reportPublic FDA data

emapalumab-lzsg 100 MG per 20 ML Injection

RxCUI
2380771
RxNorm name
emapalumab-lzsg 100 MG per 20 ML Injection
Display name
emapalumab-lzsg 100 MG per 20 ML Injection
Full name
emapalumab-lzsg 100 MG per 20 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761107Gamifantemapalumab-lzsg351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GAMIFANTEMAPALUMAB-LZSGSwedish Orphan Biovitrum AB (publ)a865e0ef-8685-4f69-8838-648c4f3bab472026-03-26Warnings, Adverse reactionsExact identifier
rxcui: 2380771

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a865e0ef-8685-4f69-8838-648c4f3bab47emapalumab-lzsg 100 MG in 20 ML Injection [PSN] · 20 ML emapalumab-lzsg 5 MG/ML Injection [SCD] · emapalumab-lzsg 100 MG per 20 ML Injection [SY]310These highlights do not include all the information needed to use GAMIFANT safely and effectively. See full prescribing information for GAMIFANT. GAMIFANT ® (emapalumab-lzsg) injection, for intravenous use Initial U.S. Approval: 201820260326